Table 4 Areas under the receiver operator characteristic curves (AUROC) for the prediction of NAFLD derived from different models in the HELENA-Trial (n = 143)
From: Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults
Included Predictors | Reference | AUROC | |
|---|---|---|---|
NAFLD liver fat score | Metabolic syndrome, Diabetes, AST, AST/ALT ratio, Insulin | Kotronen et al. 2009 [9] | 0.82 (0.75–0.89) |
Framingham Steatosis Index (FSI) | Age, Sex, BMI, Hypertension, Diabetes, ALT/AST ratio, Triglycerides | Long et al. 2016 [10] | 0.74 (0.65–0.82) |
The Hepatic Steatosis Index (HSI) | Sex, BMI, Diabetes, ALT/AST ratio | Lee et al. 2009 [11] | 0.71 (0.63–0.80) |
The Fatty Liver Index (FLI) | BMI, Waist circumference, GGT, Trygylcerides | Bedogni et al. 2006 [12] | 0.77 (0.70–0.85) |
Helena-Trial Index | Age, Sex, Waist circumference, ALT, HbA1c, HOMA-IR | Present Study | 0.85 (0.78, 0.91)a |